And our textile vertical seems to be approaching viability. Been looking at our possibilities in gene therapy, ICell sister corp at Stonybrook, CAR-T CELL articles.
China National Medical Products Association. Ahh, for info only.
CARsgen Therapeutics Receives IND Clearance for GPC3-CAR-T Cells from the NMPA Published: Jan 29, 2019 SHANGHAI, Jan. 29, 2019 /PRNewswire/LINK HERE
Dunno. Previous approvals seem to be timed in bursts by NMPA. MHO. But WHO TF am I?
The recent MOUs sort of a surprise. Why would multi-nationals sign up with an underfunded corp. But they did.